|
Volumn 120, Issue SUPPL. 4, 2010, Pages
|
Anti-EMMPRIN treatment of HNSCC in an ex vivo model
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
CASPASE 3;
CASPASE 8;
CD 147 MONOCLONAL ANTIBODY;
CD147 ANTIGEN;
MONOCLONAL ANTIBODY;
UNCLASSIFIED DRUG;
ANTIGEN EXPRESSION;
APOPTOSIS;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG RESPONSE;
ENZYME ACTIVATION;
EX VIVO STUDY;
FEASIBILITY STUDY;
HEAD AND NECK CARCINOMA;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
NICK END LABELING;
PRIORITY JOURNAL;
SQUAMOUS CELL CARCINOMA;
ADENOSINE TRIPHOSPHATE;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD147;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BLOTTING, WESTERN;
CARCINOMA, SQUAMOUS CELL;
CASPASE 3;
CASPASE 8;
FEASIBILITY STUDIES;
HEAD AND NECK NEOPLASMS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
|
EID: 78651421829
PISSN: 0023852X
EISSN: None
Source Type: Journal
DOI: 10.1002/lary.21610 Document Type: Conference Paper |
Times cited : (4)
|
References (0)
|